Literature DB >> 8038142

Absence of a direct anabolic effect of 17 beta-estradiol on normal human bone marrow stromal cells.

G S Kim1, S L Cheng.   

Abstract

The effects of 17 beta-estradiol on the proliferation and differentiation of cultured normal human bone marrow stromal cells were investigated. Treatment of 17 beta-estradiol at the concentration of 10(-6) approximately 10(-10) M for either 48 hours or 7 days did not affect [3H] thymidine incorporation. 17 beta-estradiol (10(-8)M) treatment for 4 or 7 days also failed to stimulate alkaline phosphatase activity. Similarly, incubation with 17 beta-estradiol (10(-8) M) for 48 hours did not increase the incorporation of [3H] proline into collagenase digestible protein and noncollagen proteins and secretion of IGF-I and IGF binding proteins in human bone marrow stromal cells. Present data indicate that 17 beta-estradiol does not have a direct effect on cultured normal human bone marrow stromal cells. With previous findings that estradiol elicits few effects on normal human osteoblasts, our results strongly suggest that estrogen does not have a direct anabolic effect on normal human osteoblast lineage. Therefore, the in vivo estrogen effects may be entirely through an antiresorptive mechanism or, if any anabolic role of estrogen is present, it must be indirect and mediated by other hormones or local factors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8038142      PMCID: PMC4532058          DOI: 10.3904/kjim.1994.9.1.14

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  27 in total

1.  Lack of a direct effect of estrogen on proliferation and differentiation of normal human osteoblast-like cells.

Authors:  P E Keeting; R E Scott; D S Colvard; I K Han; T C Spelsberg; B L Riggs
Journal:  J Bone Miner Res       Date:  1991-03       Impact factor: 6.741

2.  17 beta-estradiol stimulates cancellous bone formation in female rats.

Authors:  J W Chow; J M Lean; T J Chambers
Journal:  Endocrinology       Date:  1992-05       Impact factor: 4.736

3.  Estradiol stimulates in vitro the secretion of insulin-like growth factors by the clonal osteoblastic cell line, UMR106.

Authors:  T K Gray; S Mohan; T A Linkhart; D J Baylink
Journal:  Biochem Biophys Res Commun       Date:  1989-01-31       Impact factor: 3.575

4.  Release of insulin-like growth factor carrier proteins by osteoblasts: stimulation by estradiol and growth hormone.

Authors:  C Schmid; M Ernst; J Zapf; E R Froesch
Journal:  Biochem Biophys Res Commun       Date:  1989-04-28       Impact factor: 3.575

5.  Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells.

Authors:  B S Komm; C M Terpening; D J Benz; K A Graeme; A Gallegos; M Korc; G L Greene; B W O'Malley; M R Haussler
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

6.  Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins.

Authors:  B Peterkofsky; R Diegelmann
Journal:  Biochemistry       Date:  1971-03-16       Impact factor: 3.162

7.  Further characterization of insulin-like-growth factor binding proteins in rat osteoblast-like cell cultures: modulation by 17 beta-estradiol and human growth hormone.

Authors:  T L Chen; F Liu; R L Bates; R L Hintz
Journal:  Endocrinology       Date:  1991-05       Impact factor: 4.736

8.  Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.

Authors:  D P Kiel; D T Felson; J J Anderson; P W Wilson; M A Moskowitz
Journal:  N Engl J Med       Date:  1987-11-05       Impact factor: 91.245

9.  Estrogen binding and estrogenic responses in normal human osteoblast-like cells.

Authors:  D J Benz; M R Haussler; B S Komm
Journal:  J Bone Miner Res       Date:  1991-06       Impact factor: 6.741

10.  Effect of 17 beta-estradiol on the proliferation of osteoblastic MC3T3-E1 cells via human monocytes.

Authors:  M Kanatani; T Sugimoto; J Kano; M Fukase; T Fujita
Journal:  Biochem Biophys Res Commun       Date:  1991-08-15       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.